PROCEPT BioRobotics Corporation (PRCT) Misses Q4 EPS by 9c

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) reported Q4 EPS of ($0.63), $0.09 worse than the analyst estimate of ($0.54). Revenue for the quarter came in at $23.78 million versus the consensus estimate of $22.91 million.

For earnings history and earnings-related data on PROCEPT BioRobotics Corporation (PRCT) click here.

You May Also Be Interested In

• Important Notice to Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Insulet Corporation (NASDAQ: PODD); Power Solutions International, Inc. (NASDAQ: PSIX); and PROCEPT BioRobotics Corporation (
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c